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Coordination of Ribosomal Protein and Ribosomal RNA Gene Expression
in Response to TOR Signaling
LiJuan Xiao and Anne Grove*
Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA
Abstract: Cells grow in response to nutrients or growth factors, whose presence is detected and communicated by elaborate signaling pathways. Protein kinases play crucial roles in processes such as cell cycle progression and gene expression,
and misregulation of such pathways has been correlated with various diseased states. Signals intended to promote cell
growth converge on ribosome biogenesis, as the ability to produce cellular proteins is intimately tied to cell growth. Part
of the response to growth signals is therefore the coordinate expression of genes encoding ribosomal RNA (rRNA) and ribosomal proteins (RP). A key player in regulating cell growth is the Target of Rapamycin (TOR) kinase, one of the gatekeepers that prevent cell cycle progression from G1 to S under conditions of nutritional stress. TOR is structurally and
functionally conserved in all eukaryotes. Under favorable growth conditions, TOR is active and cells maintain a robust
rate of ribosome biogenesis, translation initiation and nutrient import. Under stress conditions, TOR signaling is suppressed, leading to cell cycle arrest, while the failure of TOR to respond appropriately to environmental or nutritional signals leads to uncontrolled cell growth. Emerging evidence from Saccharomyces cerevisiae indicates that High Mobility
Group (HMGB) proteins, non-sequence-specific chromosomal proteins, participate in mediating responses to growth signals. As HMGB proteins are distinguished by their ability to alter DNA topology, they frequently function in the assembly
of higher-order nucleoprotein complexes. We review here recent evidence, which suggests that HMGB proteins may function to coordinate TOR-dependent regulation of rRNA and RP gene expression.
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INTRODUCTION
Eukaryotic cell growth is regulated by intricate signaling
pathways in response to nutrient levels, environmental stress
and the presence of growth factors. Several protein kinases
contribute to such signaling, including the target of rapamycin (TOR) kinase, a highly conserved serine/threonine kinase
that plays a central role in the control of cell growth (reviewed in [1-3]). TOR is structurally and functionally conserved in all eukaryotes, and in mammalian cells, its dysregulation has been linked to many forms of cancer (reviewed in [4-7]). When growth conditions are favorable,
TOR is active; this results in cells supporting ribosome biogenesis, translation initiation and nutrient import. Under
stress conditions, TOR signaling is suppressed, resulting in
cell cycle arrest. The failure of TOR to respond appropriately
to environmental factors or nutritional signals leads to uncontrolled cell growth, as TOR signaling controls many aspects of cellular metabolism, including initiation of translation and transcription.
Up to 80% of the transcriptional machinery in Saccharomyces cerevisiae is dedicated to synthesis of ribosomal
components - rRNA by RNA polymerase (Pol) I, ribosomal
proteins by Pol II and 5S ribosomal RNA and tRNA by Pol
III - while in the proliferating mammalian cell, as much as
50% of nuclear transcription is committed to this goal. What
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has also becomes increasingly evident is that ribosome biogenesis is an important determinant of cell growth; to maintain steady growth in response to favorable conditions, about
2000 ribosomes need to be synthesized per minute. While
the role of TOR in regulating the synthesis of ribosomal
components is well established, the mechanism by which all
three polymerases are coordinately regulated in response to
appropriate stimuli remains to be fully elucidated. As reviewed here, emerging evidence points to a role for high
mobility group (HMGB) proteins in mediating such coordinated regulation in response to TOR signaling.
TOR COMPLEXES
Both yeast and mammals contain two functionally and
structurally distinct TOR complexes, TOR complex 1
(TORC1) and TOR complex 2 (TORC2), each composed of
TOR as well as subunits that determine downstream substrates [8]. TORC1 controls cell growth via a rapamycinsensitive signaling pathway [9-11] while TORC2 controls
the organization of the actin cytoskeleton through a rapamycin-insensitive signaling pathway [12-15]. While higher eukaryotes encode a single TOR homolog, yeast encodes two
TOR proteins, TOR1 and TOR2, either of which may become components of TORC1. TOR1 and TOR2 are therefore
functionally redundant as components of TORC1, which
responds to rapamycin by generating cellular responses akin
to those induced by stress or starvation, including downregulation of translation, inhibition of ribosome biogenesis,
and specific changes in gene expression. In contrast, yeast
©2009 Bentham Science Publishers Ltd.
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TOR2 is uniquely required for mediating the cell cycledependent polarization of the actin cytoskeleton and is the
kinase component of TORC2 [13, 16, 17].
The ~280 kDa TOR proteins share 40-60% sequence
identity and contain several domains. The N-terminal domain contains a number of HEAT motifs (for Huntington,
EF3, A subunit of PP2A, TOR1), required for proper subcellular localization [18]. A central FAT domain (for FRAP, an
earlier name for mammalian TOR, ATM, TRAP) may mediate protein-protein interactions [18, 19]. The C-terminal domain harbors the serine/threonine protein kinase activity.
TOR proteins belong to the phosphatidyl inositol kinaserelated kinase (PIKK) family, as their catalytic domain resembles that of the phosphatidyl inositol 3-kinases (PI3K).
The kinase domain is immediately preceded by the FKBP12rapamycin binding domain (FRB). Both TORC1 and TORC2
are multimeric complexes (Fig. (1); [14, 20]).
The response to rapamycin requires that the drug first
combine with the intracellular receptor FKBP12 [9, 21].
FKBP12-rapamycin binds TORC1 to inhibit its function.
Indeed, TOR was originally identified on the basis of mutations that confer resistance to rapamycin, which is a macrocyclic lactone produced by Streptomyces hygroscopicus as
an antifungal agent. Treatment of yeast cells with rapamycin
phenocopies nitrogen starvation or inactivation of TOR by
leading to down-regulation of protein synthesis and upregulation of macroautophagy (delivery of cytoplasmic contents
to lysosomes and vacuoles). The mechanism by which
FKBP12-rapamycin inhibits TORC1 is not known but has
been proposed to include blockage of substrate access or
dissociation of TOR from associated proteins [22, 23]. Proteins associated with TOR in yeast TORC1 have been identified as KOG1, TCO89, and LST8, of which only TCO89 has
no obvious mammalian homolog (Fig. (1)); KOG1 deficiency in yeast resembles the phenotype of rapamycin treatment, suggesting that KOG1 is a positive regulator of TOR,
an inference also reached with regard to LST8 [10, 24].
Knockdown of the mammalian KOG1 homolog (Raptor),
which interacts with downstream targets of TOR, likewise
emulates treatment with rapamycin [22, 25, 26].
TARGETS OF TORC1
Several upstream signaling cues, including growth factors in mammals, nutrients, and environmental stress such as
hypoxia and DNA damage regulate TORC1 signaling. Major
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targets of TORC1 include components of the translation machinery (reviewed in [3]). Such downstream targets include
the general translation initiation factor 4E-BP which functions to regulate availability of the initiation factor eIF4E,
essential for cap-dependent initiation of translation [27-29].
Another well-established target of the TORC1 complex is
the S6 protein kinase S6K1, which phosphorylates ribosomal
protein S6, an event that controls elongation factor 2 kinase,
but probably not translation of mRNAs with a 5'-oligopyrimidine tract as originally suggested [30-32].
TORC1-Mediated Regulation of rDNA Transcription
In addition to numerous roles in regulation of translation,
TORC1 regulates transcription of all genes whose products
are involved in ribosome biogenesis. Production of rRNA
accounts for at least 60% of total yeast transcriptional activity during normal growth, so it is a highly energy- and nutrient-consuming process. To conserve resources, cells must
therefore limit the production of new ribosomes during nutrient starvation. Accordingly, both synthesis and the subsequent processing of 35S precursor rRNA is regulated by the
TOR signaling pathway in both mammalian and yeast cells
[33, 34].
rDNA transcription is confined to the nucleolus, where
rDNA genes are arranged as hundreds of head-to-tail repeats.
The primary rRNA transcript is then processed into the mature rRNAs in the nucleolus, which is also the site of ribosome biogenesis. A recent study showed that rapamycin and
nutrient starvation causes rapid delocalization of RNA Pol I
from the nucleolus, suggesting a possible mechanism for the
regulation of rDNA transcription by TOR [35]. These
authors also found that rDNA chromatin undergoes dramatic
remodeling and becomes condensed in the presence of rapamycin. Notably, the rapamycin-mediated inhibition of
rDNA transcription was blocked by a mutation in RPD3, a
histone deacetylase subunit of the RPD3-SIN3 complex.
Since RPD3–SIN3 histone deacetylase is important for regulation of chromatin condensation in yeast, and since both
RPD3 and SIN3 were found to be rapamycin sensitive in a
genomic rapamycin-sensitivity screen, these findings suggest
that RPD3-mediated histone H4 deacetylation at rDNA
chromatin may be a critical step in rDNA transcriptional
regulation [36, 37]. Further supporting a role for chromatin
remodeling in TOR-mediated rDNA gene activity is that
RSC9, a component of the chromatin remodeling complex

Fig. (1). Domain organization of TOR kinases. Functional domains depicted include the N-terminal HEAT repeats, the central FAT domain, the kinase domain, and the C-terminal FRB domain to which FKBP12-rapamycin associates. Proteins associating with TORC1 include
TCO89, KOG1, and LST1, of which only TCO89 has no apparent mammalian homolog.
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RSC (Remodels the Structure of Chromatin), is differentially
localized to genomic DNA on TOR inactivation [38]. That
RPD3 was also reported not to be required for rapamycinmediated inhibition of Pol I points to mechanisms beyond
chromatin remodeling [39].
Like Pol II and Pol III, Pol I requires auxiliary factors to
mediate promoter recognition; for mammalian Pol I, preinitiation complex formation requires the upstream binding
factor UBF and the promoter selectivity factor TIF-IB/SL1
(TIF-IB in mouse; SL1 in humans) [40-42]. Yeast does not
encode a UBF homolog, instead the HMGB protein HMO1
has been reported to be a component of the Pol I machinery
[43], and yeast Pol I transcription also requires the multifunctional complex UAF that binds upstream of the core
promoter [44, 45]. UBF contains several HMG boxes, which
result in DNA wrapping about the UBF dimer to bring the
core promoter and upstream control element UCE into proximity, creating an “enhancesome” [46, 47]. It is thought that
this DNA conformation is required for productive interactions between UBF and TIF-IB/SL1 that manifest in recruitment of Pol I by UBF and stabilization of TIF-IB/SL1 [48].
UBF contacts Pol I directly through interaction with PAF53,
the mammalian homolog of yeast RPA49, and TIF-IB/SL1
interacts with TIF-IA, the mammalian homolog of yeast
Rrn3 [49]. TIF-1A/Rrn3 is a regulatory factor that associates
with initiation-competent subpopulations of Pol I [50, 51].
In both yeast and mammals, TOR controls transcription
by RNA polymerase I via the transcription factor TIFIA/Rrn3, as inactivation of TOR impairs formation of the
transcription initiation complex [34, 51-53]. Using chromatin
immunoprecipitation assays, it was found that rapamycin
treatment causes a decrease in the level of Rrn3-Pol I complex at the yeast rDNA promoter and coding region, similar
to what occurs in stationary phase, suggesting that the decrease in transcriptional activity of individual active genes in
stationary phase is mediated by the TOR signaling system
through Rrn3-dependent polymerase recruitment [52]. Thus,
the Pol I-Rrn3 interaction may be a major target of TORdependent regulation of rDNA transcription [51].
Changes in UBF phosphorylation are key to modulating
rDNA activity during cell cycle progression; for example,
phosphorylation of the C-terminal activation domain of UBF
by casein kinase II (CKII) facilitates the interaction between
UBF and TIF-IB/SL1 [54]. Stimulation of rDNA transcription by mTOR requires both activation of S6K1 and phosphorylation of the UBF C-terminal domain (but not directly
by S6K1; [56]). By contrast, rapamycin treatment leads to
the rapid dephosphorylation of the UBF C-terminal domain,
which significantly reduces its ability to interact with SL1
[55].
In addition to signaling functions, including the control
of cellular localization of specific transcription factors as
discussed below, TOR1 itself is dynamically distributed in
the cytoplasm and nucleus in yeast. TOR1 nuclear localization is nutrient-dependent and rapamycin sensitive, and starvation or treatment with rapamycin causes TOR1 to exit
from the nucleus. TOR1 nuclear localization is critical for
35S rRNA synthesis, but not for the expression of ribosomal
protein genes [56]. Thus, effects of TOR signaling on rRNA
gene activity appear to be exerted at the levels of both chro-
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matin remodeling and transcription factor activity, perhaps
governed by the cellular localization of TOR.
TORC1-Mediated Regulation of RP Gene Expression
Ribosomal protein (RP) genes in eukaryotes are also
regulated in response to growth stimuli and environmental
stress. Global transcription profiling revealed that RP gene
transcription is drastically repressed in response to rapamycin [33, 57]. As for rRNA gene activity, chromatin remodeling has also been implicated in regulation of RP gene expression in response to TOR signaling. For example, Rohde
and Cardenas found that expression of RP genes coincides
with recruitment of the ESA1 histone acetyl transferase to
RP gene promoters, while inhibition of TOR with rapamycin
releases ESA1 from RP gene promoters and leads to histone
H4 deacetylation. Genetic and biochemical evidence demonstrated that the chromatin deacetylation complex RPD3SIN3, also implicated in regulating rDNA gene activity, contributes to the repression of RP gene expression in response
to TOR inhibition by rapamycin or nutrient limitation [58,
59].
A number of transcription factors have been implicated
in regulation of RP gene expression. Genome-wide detection
of transcription factor binding revealed that the Forkheadlike transcription factor FHL1, originally isolated as a multicopy suppressor of RNA Pol III, is found at yeast RP gene
promoters [60, 61]. Subsequent studies found that FHL1 may
function either as a repressor or activator of RP gene transcription, depending on whether it associates with the corepressor CRF1 (Co-repressor with FHL1) or the coactivator
IFH1 (Interacts with Forkhead). This decision is made based
on the subcellular localization of CRF1, which is in turn determined by its phosphorylation state. TOR controls the subcellular localization of protein kinase A (PKA) and the PKAregulated kinase YAK1 for which CRF1 is a substrate [6264]; in actively growing cells, TORC1 negatively regulates
the activity of YAK1, keeping CRF1 in the cytoplasm, while
inhibition of TORC1 results in activation of YAK1, which in
turn phosphorylates CRF1. Phosphorylated CRF1 translocates to the nucleus where it competes with IFH1 for binding
to FHL1, which is constitutively bound at RP gene promoters [63]. The essential protein IFH1 is recruited to RP gene
promoters through the forkhead-associated domain of FHL1
[62, 64, 65]; FHL1 and IFH1 were shown to associate almost
exclusively with RP promoters, and the level of IFH1 associated with RP promoters suggested to determine the level of
transcription [64]. Accordingly, IFH1 is thought to be an
essential regulator of RP gene transcription (Fig. (2)). That
additional factors must contribute to TOR-mediated regulation of RP gene activity was indicated by the observation
that CRF1 may not be essential for rapamycin-dependent
down-regulation of RP gene activity, depending on strain
background, and that simply tethering of FHL1 to RP gene
promoters is insufficient to cause transcriptional activation,
in spite of the fact that such tethered FHL1 does recruit IFH1
[66].
Although yeast FHL1 has a domain that is related to the
DNA binding domain of the Drosophila Forkhead protein,
FHL1 was reported not to bind DNA in vitro [67]. Thus, the
binding of FHL1 to an RP promoter is likely to be either
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Fig. (2). HMO1 associates with both rRNA and RP gene promoters to coordinate gene expression in response to TORC1 activity. On
rDNA, HMO1 associates with both promoter and coding regions of transcriptionally active rDNA. Proposed functions include a role akin to
that reported for mammalian UBP in transcriptional initiation and a role in coordinating transcriptional elongation with pre-rRNA processing, to which Utp22 and Rrp7 contribute. On most RP gene promoters, Rap1 sites are further upstream than on other Rap1-dependent genes,
and association of Rap1 appears to be required for the subsequent cooperative binding of HMO1 and FHL1 at IFHL sites. When TORC1 is
active, the coactivator IFH1 binds FHL1 to activate RP gene transcription. When TORC1 is inactive, phosphorylated CRF1 translocates to
the nucleus to compete with IFH1 for binding to FHL1 and repress transcription. IFH1 is found in the “CURI” complex also containing
Utp22, Rrp7, and CKII, with which FHL1 also associates. HMO1 dissociates from both classes of genes on inactivation of TORC1.

indirect or facilitated by other proteins. One such candidate
for FHL1 recruitment is the repressor-activator protein 1
(Rap1), long known to be involved in the transcription of RP
genes; most RP genes contain Rap1 binding sites at their
promoters [68, 69]. However, Rap1 binds to many sites in
the yeast genome and acts as an activator at some and as a
repressor at others, as its name implies. Further, not all RP
gene promoters contain Rap1 binding sites [70], suggesting
that additional protein(s) contribute to FHL1 recruitment.
The complexity of the TOR pathway is further underscored by the reported involvement of yet another transcription factor, Sfp1, a key cell size regulator, in regulating RP
gene expression in response to nutrients and stress [71]. Under optimal growth conditions, Sfp1 is localized to the nucleus, bound to the promoters of RP genes where it activates
RP gene expression. In response to inhibition of TOR signaling, Sfp1 is released from RP gene promoters, and downregulation of RP gene transcription occurs concomitant with
Sfp1 leaving the nucleus. That Sfp1 remains localized to the
nucleus in a strain constitutively expressing high PKA activity in spite of rapamycin treatment suggests that Sfp1 may be
regulated by the branch of the TOR pathway that depends on
PKA, similar to the regulation of CRF1 localization [63, 71].
Analysis of genetic interactions further suggested that Sfp1
influences RP gene transcription via FHL1 and IFH1, and
that the association of IFH1 and FHL1 with RP gene promoters was reduced by approximately four-fold and twofold, respectively, in sfp1 cells [72]. As for the role of
CRF1 in communicating downstream signals of the TOR
pathway, the role of Sfp1 may be strain-dependent, as a sub-

sequent genome-wide ChIP analyses suggested only limited
association of Sfp1 with RP genes [73]. Thus, while different
transcription factors have been variously implicated in mediating responses to TOR signaling, suggesting the existence
of more than one mechanism by which such signals are converted to changes in gene activity, signaling through FHL1
appears to be the primary pathway.
Coordination of rRNA and RP Gene Expression in Response to TOR Signaling
As summarized above, an effect of TOR inactivation on
rRNA and RP gene expression has been well established,
although the molecular basis for the response remains to be
fully elucidated. Notably, recent evidence has finally furnished a link that may provide a clue to the mechanism by
which transcriptional activity of the different RNA polymerase machineries may be coordinated in response to TOR
signaling. This link comes in the form of the yeast HMGB
homolog HMO1. HMGB proteins are conserved architectural proteins that bind DNA without sequence specificity,
but with preference for DNA with structural distortions. As
for mammalian HMGB homologs, HMO1 is composed of
two HMG boxes, box A and box B. Box A has low affinity
for DNA but is required for DNA structural specificity and
for DNA bending, whereas box B is required for high affinity DNA binding [74, 75]. Genetic analysis showed that
HMO1 is important for maximal transcription of rDNA [43].
While the molecular basis for the involvement of HMO1 in
Pol I transcription is unknown, it is noteworthy that HMO1
overexpression suppresses an rpa49 mutation, as RPA49
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corresponds to the mammalian PAF53 which interacts directly with the HMG-box-containing transcription factor
UBF; as noted above, yeast does not encode a UBF homolog
[43, 48, 49]. It is therefore tempting to speculate that HMO1
may serve to configure the yeast Pol I promoter for optimal
transcriptional activity, akin to the enhancesome structure
proposed for UBF [46, 47].
A seminal study by Hall and coworkers demonstrated
that HMO1 associates throughout the rDNA locus [76].
Their study also confirmed that HMO1 is required for
maximal transcription of rRNA genes and demonstrated a
role for HMO1 in rRNA maturation. Considering the localization of HMO1 throughout the rDNA locus, its reported
role in rRNA processing, and recent evidence linking RNA
Pol I transcriptional elongation with rRNA maturation, it is
conceivable that HMO1 participates in coordinating these
activities [77]. Importantly, HMO1 was also found to associate with most RP gene promoters and to do so in a Rap1dependent fashion [76]. While Rap1 appears to be required
for association of HMO1 with RP gene promoters, it is not
sufficient, as evidenced by its localization to other genomic
loci to which HMO1 does not associate. Notably, HMO1
association is reduced in an fhl1  strain, while inactivation
of HMO1 completely eliminates association of FHL1 and
IFH1 with RP genes [76]. These data indicate that HMO1
and FHL1 bind cooperatively to RP gene promoters, and that
Rap1 may promote this association.
Using a global genetic approach, Berger et al. subsequently reported that HMO1 specifically interacts with the
Pol I-transcribed region of the rDNA locus, pointing to a role
in elongation, and confirmed its association with a subset of
RP gene promoters [78]. This is consistent with an independent report indicating that HMO1 associates with the 35S
rRNA gene in an RNA Pol I-dependent manner [73]. Notably, HMO1 was seen to dissociate from both rDNA and
some RP gene promoters upon rapamycin treatment, and
HMO1 deletion was shown to reduce the TORC1-dependent
repression of RP gene expression [78]. These results clearly
link HMO1 to the rapamycin-dependent TOR pathway and
suggest that HMO1 is involved in coordinating rDNA transcription by Pol I and RP gene expression by Pol II in response to TOR signaling.
CONCLUSION
The molecular mechanisms underlying the role of HMO1
in coordinating rRNA and RP gene transcription in response
to TOR-mediated signals remain to be determined. In the
case of rDNA, HMO1 has been proposed to serve roles akin
to those fulfilled by UBF in mammalian transcriptional initiation as well as in linking transcriptional elongation with
pre-rRNA processing. Regardless of its specific function(s),
it is clear that HMO1 abandons the rDNA locus when
TORC1 is inhibited [78]. For UBF, dephosphorylation in
response to rapamycin treatment is accompanied by reduced
recruitment of Pol I [55]. Whether HMO1 is likewise subject
to covalent modification in a rapamycin-dependent fashion
remains to be determined.
At RP gene promoters, several transcription factors have
been implicated in mediating downstream effects of TOR
signaling. While the role of Sfp1 appears particularly uncer-
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tain, a consensus is emerging based on consistent reports
from several groups (Fig. (2)). At most RP gene promoters,
HMO1 appears to associate in a Rap1-dependent fashion,
followed or accompanied by FHL1; however, at the promoters to which HMO1 only associates modestly, FHL1 binding
appears independent of HMO1 [73]. The transcription factor
IFH1 is essential, consistent with its reported role as a coactivator of RP gene transcription; if IFH1 is absent, the corepressor CRF1 would also encounter no competition for
binding to FHL1, thus potentially abolishing even basal levels of RP transcription. Depending on genetic background, a
rapamycin-mediated down-regulation of RP gene activity
may still be seen when CRF1 is inactivated; however, the
basis for this observation remains unknown and has been
suggested to involve more than one gene product [66]. One
possible clue derives from the observation that IFH1 is found
to a significant extent in a complex named CURI, composed
of casein kinase II (CKII), Utp22, Rrp7 and IFH1), a complex with which FHL1 also loosely associates [79]. Notably,
both Utp22 and Rrp7 have been implicated in pre-rRNA
processing, a process in which HMO1 is also involved. It is
possible that TOR-dependent sequestration of IFH1 in the
CURI complex limits its availability as an RP gene activator,
causing down-regulation of RP gene expression on inhibition
of the TOR pathway. Activation of rDNA transcription may
lead to disruption of CURI as Utp22 and Rrp7 engage in prerRNA processing, thus releasing IFH1 to activate RP gene
expression [79]. Whether HMO1 participates in this proposed scenario has not been addressed; however, HMO1 has
been reported to interact directly with Utp22 [80], consistent
with both proteins participating in pre-rRNA processing,
suggesting the possibility that CURI may be recruited to
both rRNA and RP genes by interaction with HMO1.
As HMO1 is non-sequence-specific in its DNA binding
[74, 75], it is likely recruited to RP gene promoters by association with sequence-specific factors; that FHL1 fails to
bind DNA in vitro, even in the presence of Rap1 [67], combined with the co-dependence of HMO1 and FHL1 for binding to RP genes [76], suggests that HMO1 (or another factor,
perhaps Sfp1) may be required to stabilize it on the DNA.
HMO1 was reported either to have no effect or to cause a
mild activation of RP gene transcription [76, 78]; such effects may be due to its interaction with TFIID, which has
been reported to affect occupancy of TFIID at certain RP
gene promoters as well as to participate in start site selection
of a subset of Pol II genes [81]. As for rDNA, the mechanism by which HMO1 leaves the RP gene promoters following inhibition of the TOR pathway is not known.
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